Anakinra shows promise for treating patients with rheumatoid arthritis

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)

Volumn 42, Issue 4, 2002, Pages 660-662

  McIntosh, Tera ^a,b   Freeman, Trish R ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b American Pharmacy Services Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

ARTICLE; CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 0036631946     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1331/108658002763029661     Document Type: Article

References (13)

1. S.N. Blumberg D.A. Fox Rheumatoid arthritis: guidelines for emerging therapies Am J Manag Care. 7 2001 617 626
2. Rheumatoid Arthritis Fact Sheet. American College of Rheumatology Web site. Available at: www. rheumatology.org/patients/ factsheet/ra.html Accessed April 1, 2002.
3. J.M. Dayer U. Feige C.K. Edwards III D. Burger Anti-interleukin–1 therapy in rheumatic diseases Curr Opin Rheumatol. 13 2001 170 176
4. M.H. Schiff Role of interleukin-1 and interleukin-1 receptor antagonist in the mediation of rheumatoid arthritis Ann Rheum Dis 59 suppl 1 2000 i103 i108
5. W.P. Arend Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist Semin Arthritis Rheum 30 5 suppl 2 2001 1 6
6. G.S. Firestein Rheumatoid synovitis and pannus J.H. Klippel P.A. Dieppe Rheumatology 1998 Mosby International London, UK 5.13.1 5.13.24
7. Kineret 2001 Amgen Inc Thousand Oaks, Calif
8. S. Cohen L. Moreland J. Cush Anakinra (recombinant interleukin-1 receptor antagonist): a large, placebo controlled efficacy trial of anakinra in patients with erosive rheumatoid arthritis disease Arthritis Rheum 44 suppl 19 2001
9. Guidelines for the management of rheumatoid arthritis Arthritis Rheum 46 2002 328 346
10. S. Cohen E. Hurd J. Cush Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial Arthritis Rheum. 46 2002 574 578
11. B. Bresnihan G.M. Alvaro-Garcia M. Cobby Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthtitis Rheum. 41 1998 2196 2204
12. R. Fleischman J. Tesser J. Schechtman A safety trial of anakinra: recombinant interleukin-1 receptor antagonist (IL-IRA) in a large, placebo controlled heterogeneous population of patients with rheumatoid arthritis Arthritis Rheum 44 suppl 9 2001 S84
13. 2001 Drug Topics Red Book 2001 Medical Economics Publishers Montvale, NJ